Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.850
+0.040 (0.83%)
Nov 22, 2024, 4:00 PM EST - Market closed
Aldeyra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 289 | 206 | 408 | 232 | 266 | 162 | |
| Market Cap Growth | -18.17% | -49.34% | 75.40% | -12.74% | 63.98% | -25.44% | |
| Enterprise Value | 232 | 79 | 260 | 132 | 210 | 127 | |
| Last Close Price | 4.85 | 3.51 | 6.96 | 4.00 | 6.86 | 5.81 | |
| PB Ratio | 3.39 | 1.72 | 2.70 | 1.13 | 4.48 | 3.38 | |
| P/TBV Ratio | 3.76 | 1.72 | 2.70 | 1.13 | 4.48 | 3.38 | |
| Debt / Equity Ratio | 0.18 | 0.13 | 0.11 | 0.08 | 0.26 | 0.31 | |
| Quick Ratio | 4.24 | 6.42 | 11.56 | 8.90 | 4.26 | 3.51 | |
| Current Ratio | 6.80 | 6.64 | 11.78 | 19.77 | 6.69 | 5.82 | |
| Return on Equity (ROE) | -43.05% | -27.73% | -34.77% | -43.56% | -69.81% | -90.31% | |
| Return on Assets (ROA) | -23.45% | -16.23% | -18.91% | -22.20% | -27.28% | -41.40% | |
| Return on Capital (ROIC) | -25.86% | -17.68% | -20.16% | -23.71% | -31.48% | -47.26% | |
| Earnings Yield | -15.51% | -18.18% | -15.22% | -24.86% | -14.10% | -37.45% | |
| FCF Yield | -10.62% | -14.69% | -13.90% | -18.32% | -14.08% | -27.70% | |
| Buyback Yield / Dilution | -1.03% | -0.92% | -8.07% | -59.11% | -25.28% | -25.02% | |
| Total Shareholder Return | -1.03% | -0.92% | -8.07% | -59.11% | -25.28% | -25.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.